Oppenheimer Asset Management Inc. Apellis Pharmaceuticals, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $8.04 Billion
- Q3 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 12,636 shares of APLS stock, worth $416,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,636
Previous 12,754
0.93%
Holding current value
$416,482
Previous $489,000
25.56%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$513 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$392 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$366 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$324 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$191 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.62B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...